Tekin et al., “Antiglutamatergic therapy in Alzheimer's disease-effects of lamotrigine,” J. Neural. Transm., vol. 105, pp. 295-303, 1998.* |
Database CAPLUS on STN, Chemical Abstract, vol. 121, No. 134062, Parasharya et al., 4-(3H)-Quinazolones: 2-N-aryl/alkylaminomethyl/ethyl-3-p-hydroxyphenyl/p-anisyl/p-arylaminoacyloxyphenyl/p-N-arylcarbamoylmet abstract, J, 1992.* |
MEDLINE abstract No. 96027110: “Excitatory amino acid receptors and neurodegeneration,” Therapie, vol. 50, No. 4, pp. 319-337, 1995.* |
Meldrum, B.S. Current Opinion in Neurology and Neurosurgery, vol. 5, 1992, pp. 508-513.* |
Kappelle, L.J. et al. Pharmaceutisch Weekblad, vol. 132 No. 31, 1997, pp. 1117-1123.* |
Jackson, C.E. et al. Seminars in Neurology, vol. 18, No. 1, 1998, pp. 27-39.* |
Hughes, A.J. Drugs, vol. 53, No. 2, 1997, pp. 195-205.* |
Greenamyre, J.T. Neurobiology of Aging, 1989, vol. 10, pp. 593-602.* |
Medline abstract No. 92274400: Giuffra, M.E. et al. Clinical Neuropharmacology, 1992, vol. 15, No. 2, pp. 148-151.* |
Medline abstract No. 97339045: Montastruc, J.L. et al. Neuroscience and Biobehavioural Reviews, 1997, vol. 21, No. 4, pp. 477-480.* |
Chalmers et al. TiPS, 1996, vol. 17, pp. 166-172.* |
Frampton et al. Drugs and Aging, 1995, vol. 7, No. 6, pp. 480-503.* |
Lyrer Schweiz. Med. Wochenschr. 1994, vol. 124, No. 45, pp. 2005-2012.* |
Amin et al., Synthesis and Reactions of 2-Chloromethyl-3,1-Benzoxazin-4-ones with Amines, Egypt. J. Chem., vol. 38, No. 1, pp. 113-123, 1995.* |
Amin et al., Chem. Abstract 125:10737j, 1996.* |
Watkins, J.C., and Evans, R.H., Excitatory Amino Acid Transmitters, Annu. Rev. Pharmacol. Toxicol. 21, pp. 165-204 (1981). |
Monaghan, Daniel T., et al., The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous System, Annu. Rev. Pharmacol. Toxicol. 29 pp. 365-402 (1989). |
Watkins, Jeff C., et al., Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists, TIPS-(vol. 11) pp. 25-33 Jan. 1990. |
Schoepp, Darryle, et al., Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors, TIPS-(vol. 11) pp. 508-515 Dec. 1990. |
McDonald, John W. and Johnston, Michael V., Physiological and pathophysiological roles of excitatory amino acids during central nervous system development, Brain Res. Reviews 15, pp. 41-70 (1990). |
Sheardown, Malcom J., et al., 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F) quinoxaline: A Neuroprotectant for Cerebral Ischemia, Science Reports, vol. 247, pp. 571-574 Feb. 2, 1990. |
Buchan, Alastair M., et al., Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia, NeuroReport 2, No. 8, pp. 473-476 (1991). |
Le Peillet, Elaine, et al., The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat, Brain Res. 571, pp. 115-120 (1992). |
Parks T.N., et al., Modulation Of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells, Brain Res. 552, pp. 13-22 (1991). |
Physicians' Desk Reference, 53 Ed., 1999, pp. 2604-2607. |